Senti Bio aims to improve cancer therapeutics with customizable gene circuits, or multi-gene constructs capable of ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

Scientists discover that the CD74 protein could predict the effectiveness of immunotherapy, advancing colon cancer treatment.

Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...

Purple Biotech (PPBT) announced that it has entered into a Research Collaboration Agreement with the Icahn School of Medicine at Mount Sinai in ...

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the ...

Following a healthy diet is essential in preventing and fighting cancer, but research now says the way you eat could play a ...

LUND, SE / ACCESS Newswire / January 29, 2025 / Alligator Bioscience (STO:ATORX) Publication validates encouraging clinical ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

LOS ANGELES - INmune Bio , Inc. (NASDAQ:INMB), a clinical-stage biotech company valued at $175 million, has announced the treatment of the first patient in the Phase II segment of its ongoing clinical ...

First patient treated in Phase II portion of clinical trial in metastatic prostate cancer at the West Los Angeles Veterans Administration ...

This growth highlights the sector’s role in transforming healthcare, particularly in oncology, autoimmune diseases, and neurological disorders.